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Hereditary sensory neuropathy type I (HSN1) is the most common dominantly inherited degenerative disorder of
sensory neurons. The gene mutation was mapped to chromosome 9 in a large Australian family, descended from
an ancestor from southern England who was a convict. Dawkins et al. recently reported gene mutations in the
SPTLC1 gene, in this and other families. The first description of hereditary sensory neuropathy, by Hicks, was in
a family from London and Exeter. To determine if the families in the present study that have SPTLC1 mutations
are related to English families with HSN1 and, possibly, to the family studied by Hicks, we performed haplotype
analysis of four Australian families of English extraction, four English families, and one Austrian family. Three
Australian families of English extraction and three English families (two of whom have been described elsewhere)
had the 399TrG SPTLC1 mutation, the same chromosome 9 haplotype, and the same phenotype. The Australian
and English families may therefore have a common founder who, on the basis of historical information, has been
determined to have lived in southern England prior to 1800. The sensorimotor neuropathy phenotype caused by
the 399TrG SPTLC1 mutation is the same as that reported by Campbell and Hoffman and, possibly, the same
as that originally described by Hicks.
Hereditary sensory neuropathy type I (HSN1 [MIM
162400]) is a dominantly inherited sensorimotor axon-
al neuropathy accompanied by variable sensorineural
deafness (for review, see Thomas 1993). The presence
of severe sensory loss leads to painless injuries, chronic
skin ulcers, and distal amputations, distinguishing the
disorder from other dominantly inherited sensorimo-
tor neuropathies—such as Charcot-Marie-Tooth (CMT)
type 2 syndromes—although, occasionally, patients with
CMT type 1 or 2 develop skin ulcers.
In past literature, there have been many terms for this
disease, including “trophoneurosis,” “lumbosacral sy-
ringomyelia,” and “ulcero-mutilating acropathy.” This
literature has been reviewed by Dyck et al. (1993), who
classified the disease as hereditary sensory and auto-
nomic neuropathy (Dyck et al. 1993); however, frank
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autonomic symptoms and signs are rare in the families
in the present study, but motor signs are present in all
but early cases.
An English family with a phenotype similar to that of
the large Australian family described elsewhere and
herein (family 1 in this report) was reported, by Hicks
(1922), as having hereditary perforating ulcer of the
foot. The same family was later reported, by Denny-
Brown (1951), as having hereditary sensory radicular
neuropathy. One year later, the same family was reported
as having peroneal muscular atrophy with severe sensory
changes (England and Denny-Brown 1952), a descrip-
tion that recognized motor involvement. These reports
underlie the overlap between HSN1 and the other dom-
inantly inherited hereditary sensorimotor neuropathies
(e.g., CMT neuropathies). This problem was recognized
by Dyck et al. (1993), who felt that an improved clas-
sification would depend on identification of the gene
abnormality.
Foot ulcers are common in an axonal form of CMT
type 2 neuropathy linked to chromosome 3 (Kwon et
al. 1995; De Jonghe et al. 1997). This form of CMT
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Figure 1 Physical map of interval between D9S1836 and D9S197, showing relative positions of markers used to define HSN1 haplotype.
The markers shown in boldface define the boundaries of the HSN1 critical interval (D9S1781–D9S197) described elsewhere. The three new
microsatellite markers (71J15, 20L24, and 20L24TA) all map to bin 5. SPTLC1 maps to bin 3.
could also be classified as hereditary sensory neuropathy
(Vance et al. 1996).
We have used the term “HSN1” to describe this form
of dominantly inherited sensorimotor axonal neuropa-
thy with variable sensorineural deafness (Thomas 1993).
We previously mapped the HSN1 locus to chromosome
9 (Nicholson et al. 1996), in the large Australian family
(family 1) with clinical features similar to those in the
London/Exeter family studied by Hicks (1922) and
Denny-Brown (1951), and recently found mutations in
the SPTLC1 gene (Dawkins et al. 2001), both in family
1 and in 10 other families with HSN1. The Australian
family was originally described as having familial lum-
bosacral syringomyelia (Jackson 1949), and, later, the
same family was reported as having hereditary sensory
radicular neuropathy (Wallace 1969, 1970). HSN1 is
genetically heterogeneous, with at least three loci: chro-
mosome 9 (Nicholson et al. 1996; Bejaoui et al. 1999);
a chromosome 3 locus (Kwon et al. 1995), for a form
of CMT type 2 suggested to be similar to HSN1 (Vance
et al. 1996); and at least one other locus, for families
without linkage to either of these two loci (Auer-Grum-
bach et al. 2000).
To determine whether the Australian and English fam-
ilies have a common founder and whether the phenotype
described by us is likely to be the same as that originally
described by Hicks (1922), we generated additional mi-
crosatellite markers and constructed a disease haplotype
for each family. Multigenerational families with a di-
agnosis of HSN1 and with mutations in SPTLC1 were
selected. The clinical diagnosis of HSN1 was based on
(1) a history of either chronic skin ulcers or painless
injuries, (2) gross sensory loss in all modalities, and (3)
electrophysiological evidence of a chronic axonal neu-
ropathy. Severe, brief shooting pains were characteristic
of HSN1 but were not a selection criterion. Sensorineu-
ral deafness was present in some members of some fam-
ilies. Australian families 1, 2, 4, and 6 have been de-
scribed elsewhere (but identified as families 1, 3, 2, and
4, respectively; Nicholson et al. 1996). One of the Eng-
lish families (family 24) has previously been character-
ized, by Campbell and Hoffman (Campbell and Hoff-
man 1964), as family X.
Fourteen microsatellite markers on chromosome 9
were analyzed in each of the nine families with HSN1,
as well as in the control individuals. These markers in-
cluded three new polymorphic microsatellites (71J15,
20L24, and 20L24TA) that we isolated from cosmids
within the HSN1 critical region. All 14 microsatellite
markers were localized to our 8-Mb yeast-artificial-chro-
mosome (YAC)–based physical map of the HSN1 critical
interval (Blair et al. 1998). Figure 1 shows the locations
of the 3 new markers and of 13 markers described else-
where, in relation to the HSN1 critical interval and our
YAC-based physical map. The order of markers within
individual expressed-sequence-tag (EST) bins was deter-
mined, when possible, by use of information from pub-
lished linkage maps (Genome Database), as well as by
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use of sequence data and bacterial-artificial-chromosome
(BAC) contig maps of the region that, as part of their
project to sequence chromosome 9, were generated by
the Sanger Centre.
For each of the 14 markers, alleles associated with
HSN1 were identified in each family with HSN1, and a
disease haplotype was constructed. Haplotypes spanning
these markers were also determined in 50 controls (100
chromosomes), consisting of those married-in spouses
and individuals of known English extraction for whom
samples were available from three generations. Statis-
tical analysis, to compare the frequency of disease-car-
rying haplotypes to that of controls, was performed by
the test, with 1 df and the Yates continuity correction2x
for a contingency table.2# 2
Only two families with HSN1 were large enough to
show definite linkage (LOD score 13) to chromosome
9. Maximum LOD scores for each family are shown in
table 1. Linkage to chromosome 9 was not excluded in
any family. Most families were too small to yield a sig-
nificant LOD score, but, in each of these small families,
we were able to identify a disease haplotype that was
shared by all affected family members. No recombina-
tion events within the HSN1 critical interval were ob-
served in any individuals in these families.
Table 1 shows HSN1 chromosome haplotypes. An
extended haplotype spanning the nine markers—
D9S1836, D9S1796, D9S255, D9S1815, D9S1841,
D9S1781, 71J15, 20L24, and 20L24TA—was present
in 6 of the 9 disease chromosomes studied but in 0 of
the 100 control chromosomes studied ( ;2x p 58.32
). These results provide strong evidence for aP ! .0001
common founder for these families. A group of common
alleles was found, with markers 71J15, 20L24, and
20L24TA, in 2 of the 9 disease chromosomes (in families
4 and 16), compared to 28 of the 100 control chro-
mosomes, but this smaller haplotype was not statistically
significant ( ; ). Families 4 and 16 ex-2x p 0.00 Pp .986
hibit different SPTLC1 mutations, providing further ev-
idence against a common founder for these two families.
Five of the six families with HSN1 who share the
9-marker haplotype, from D9S1836 to 20L24TA,
have a larger haplotype—spanning 14 markers, from
D9S1836 to D9S197 (table 1); family 2 shares the
common 9-marker haplotype, to marker 20L24TA,
but the haplotype diverges at the next marker, D9S151
(see table 1), indicating a historical recombination be-
tween D9S151 and the gene mutation.
In this study, we have identified, in the largest of the
families that we studied (family 1), an HSN1 haplotype
that is common to families 2, 6, 22, 23, and 24. Given
the strong statistical evidence ( ), it is highlyP ! .0001
unlikely that the common haplotype occurs by chance.
No control families of English extraction had the same
haplotype, indicating that the common haplotype was
present in !1/50 families. These results suggest a com-
mon founder for the three Australian and the three Wilt-
shire families with HSN1.
One of the Wiltshire families with the common hap-
lotype had come from London and therefore may be
related to the London/Exeter family studied by Hicks
(1922), but no records for the London/Exeter family can
be found. The clinical phenotype in the families with the
common chromosome 9 haplotype is similar to that in
the family studied by Hicks (1922), with frequent but
not invariable deafness, severe shooting or lancinating
pains in some affected individuals, and late-teenage– or
adult-onset CMT type 2. This lancinating pain/deafness
HSN1 phenotype was recognized by Dyck et al. (1993).
Family 20, an Austrian family, has this phenotype as
well as a different SPTLC1 mutation with a different
haplotype, suggesting a separate founder.
Shooting pains and deafness were not reported in either
the families with chromosome 3 linkage (De Jonghe et al.
1997; Elliott et al. 1997) or the family in which loci of
chromosomes 3 and 9 were excluded (Auer-Grumbach et
al. 2000). These associated features may therefore help
to distinguish between families with HSN1 and families
with other forms of hereditary sensory neuropathy and
CMT neuropathy.
The haplotype information suggests that a number of
Australian and English families are descended from a
common southern-English founder; this is supported by
our finding the same phenotype and mutation (399TrG)
in such families. Historical information shows that the
founder lived in southern England prior to 1800, the
date of deportation, from Wiltshire, of the convict an-
cestor of family 1 (Wallace 1969). The neuropathy phe-
notype caused by the 399TrG SPTLC1 mutation is the
same as that reported by Campbell and Hoffman (1964)
and, possibly, the same as that originally described by
Hicks (1922). It is interesting that the family with the
historical recombination (family 2) migrated to Australia
from Trowbridge, a town in Wiltshire, near where three
of the English families with HSN1 live.
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